BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 18393400)

  • 21. A review of high throughput technology for the screening of natural products.
    Mishra KP; Ganju L; Sairam M; Banerjee PK; Sawhney RC
    Biomed Pharmacother; 2008 Feb; 62(2):94-8. PubMed ID: 17692498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [High content drug screening and its application].
    Zhang L; Du GH
    Yao Xue Xue Bao; 2005 Jun; 40(6):486-90. PubMed ID: 16144310
    [No Abstract]   [Full Text] [Related]  

  • 23. Furans, thiophenes and related heterocycles in drug discovery.
    Sperry JB; Wright DL
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):723-40. PubMed ID: 16312148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries.
    Lee ML; Schneider G
    J Comb Chem; 2001; 3(3):284-9. PubMed ID: 11350252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural product-likeness score and its application for prioritization of compound libraries.
    Ertl P; Roggo S; Schuffenhauer A
    J Chem Inf Model; 2008 Jan; 48(1):68-74. PubMed ID: 18034468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scaffold diversity of natural products: inspiration for combinatorial library design.
    Grabowski K; Baringhaus KH; Schneider G
    Nat Prod Rep; 2008 Oct; 25(5):892-904. PubMed ID: 18820757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wanted: new multicomponent reactions for generating libraries of polycyclic natural products.
    Ulaczyk-Lesanko A; Hall DG
    Curr Opin Chem Biol; 2005 Jun; 9(3):266-76. PubMed ID: 15939328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical appraisal of structure-based drug design.
    Tintelnot-Blomley M; Lewis RA
    IDrugs; 2006 Feb; 9(2):114-8. PubMed ID: 16523401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural products to drugs: natural product derived compounds in clinical trials.
    Butler MS
    Nat Prod Rep; 2005 Apr; 22(2):162-95. PubMed ID: 15806196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous flow microreactors for drug discovery.
    Watts P
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):807-12. PubMed ID: 15595441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yin and Yang in medicinal chemistry: what does drug-likeness mean?
    MacarrĂ³n R; Luengo JI
    Future Med Chem; 2011 Apr; 3(5):505-7. PubMed ID: 21526891
    [No Abstract]   [Full Text] [Related]  

  • 32. Engineering natural products using combinatorial biosynthesis and biocatalysis.
    Zhou H; Xie X; Tang Y
    Curr Opin Biotechnol; 2008 Dec; 19(6):590-6. PubMed ID: 18992814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biaryl formation involving carbon-based leaving groups: why not?
    Bonesi SM; Fagnoni M; Albini A
    Angew Chem Int Ed Engl; 2008; 47(52):10022-5. PubMed ID: 19035599
    [No Abstract]   [Full Text] [Related]  

  • 34. Race for molecular summits.
    Service RF
    Science; 1999 Jul; 285(5425):184-5, 187. PubMed ID: 10428711
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of flavonoid analogues as scaffolds for natural product-based combinatorial libraries.
    Yao N; Song A; Wang X; Dixon S; Lam KS
    J Comb Chem; 2007; 9(4):668-76. PubMed ID: 17487987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive survey of combinatorial library synthesis: 2005.
    Dolle RE; Le Bourdonnec B; Morales GA; Moriarty KJ; Salvino JM
    J Comb Chem; 2006; 8(5):597-635. PubMed ID: 16961395
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial.
    Chaguturu R
    Comb Chem High Throughput Screen; 2012 Jan; 15(1):1-2. PubMed ID: 22417084
    [No Abstract]   [Full Text] [Related]  

  • 38. Natural products to drugs: natural product-derived compounds in clinical trials.
    Butler MS
    Nat Prod Rep; 2008 Jun; 25(3):475-516. PubMed ID: 18497896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicomponent reactions in solid-phase synthesis.
    Banfi L; Guanti G; Riva R; Basso A
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):704-14. PubMed ID: 17987522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of additive/nonadditive effects in structure-activity relationships: implications for iterative drug design.
    Patel Y; Gillet VJ; Howe T; Pastor J; Oyarzabal J; Willett P
    J Med Chem; 2008 Dec; 51(23):7552-62. PubMed ID: 19012393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.